Subscribe To
Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc
The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate...
November 4, 2023, 12:00 pm
Cinemark q3 revenue surges above pre-pandemic levels; theater chain “highly optimistic” about future of moviegoing
Cinemark revenue set a record in the third quarter, thanks to blockbusters like Barbie and Oppenheimer, and even notched a 6% gain over pre-pandemic 2...
November 3, 2023, 7:19 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...
November 2, 2023, 9:09 am
Immunic gets notice of allowance for us patent protecting treatment of relapsing ms with vidofludimus and salts
Immunic Inc (NASDAQ:IMUX) told investors it has received a Notice of Allowance from the US Patent and Trademark Office for a patent application protec...
November 2, 2023, 8:13 am
Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
November 2, 2023, 6:30 am
Zyversa therapeutics announces publication in molecular neurobiology reinforcing data demonstrating that inflammasome asc inhibitor ic 100 attenuates the inflammatory response causing neuronal damage
Molecular Neurobiology publication demonstrated that NLRP3 inflammasomes have an important role in the pathogenesis of multiple sclerosis (“MS”) b...
November 1, 2023, 12:07 pm
Scancell melanoma trial data chosen for poster presentation at sitc
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) told investors that it has been selected for a poster presentation of data from the first stage of its Pha...
November 1, 2023, 4:16 am
Paybito chief predicts ‘the future is bright’ after the recent bitcoin surge
The surge in the value of Bitcoin has been a topic of interest for many investors and experts in the industry. Pay...
October 31, 2023, 7:14 am
First bitcoin etf trades $1.5b as gbtc ‘discount’ echoes $69k btc price
Notable: $bito traded $1.7b last week, 2nd biggest week since its wild WEEK ONE. $GBTC did $800m. That�...
October 29, 2023, 8:59 am
Imax ceo says “i will feel a lot better” if strike settles by thanksgiving, but it only needs one film at a time
Imax CEO Rich Gelfond predicts the long SAG-AFTRA strike will settle relatively soon. If, instead, it drags on, theater chains will face a rocky secon...
October 25, 2023, 12:55 pm
Acceptance of polyamine inhibitor car-t combination abstract for online publication
MINNEAPOLIS, Oct. 25, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics...
October 25, 2023, 12:15 pm
Geron corporation stock: another buying opportunity
Geron Corporation stock has nearly halved since July, leading to concerns about whether the price will go back up. Geron's telomerase inhi...
October 23, 2023, 3:30 pm
Strong global entertainment, inc. to present at the fall foliage microcap rodeo virtual conference
CHARLOTTE, NC / ACCESSWIRE / October 23, 2023 / Strong Global Entertainment, Inc. (NYSE American:SGE) ("SGE" or the "Company") today announced that Ma...
October 23, 2023, 1:45 pm
Revolution medicines presents promising clinical activity and safety data from phase 1/1b trial of rmc-6236
Investor Webcast to be held Sunday, October 22 at 12:30 p.m. Eastern Time REDWOOD CITY, Calif., Oct. 22, 2023 (GLOBE NEWSWIRE) — Revolution Medicine...
October 22, 2023, 6:30 am
Initial phase 1 dose escalation data of oric-114 in patients with egfr and her2 exon 20 mutations demonstrates potential best-in-class profile
CNS activity observed at multiple dose levels, including the first reported confirmed CNS complete response by an EGFR exon 20 inhi...
October 21, 2023, 11:30 am
Cinemark to host third quarter 2023 earnings conference call
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (“Cinemark”) (NYSE: CNK), one of the largest motion picture exhi...
October 20, 2023, 8:30 am
Cytomx therapeutics presents preclinical profile of epcam-directed antibody drug conjugate cx-2051 at 2023 world adc conference
– CX-2051 is tailored for treatment of EpCAM-expressing cancers by matching target expression and tumor sensitivity with a topoisomerase-1 inhi...
October 18, 2023, 8:30 pm
Sagimet biosciences to present at the h.c. wainwright 7th annual nash investor conference
SAN MATEO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing no...
October 18, 2023, 4:05 pm
Omega therapeutics presents new preclinical data supporting the potential of otx-2101 in combination settings for treatment of nsclc
Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced ...
October 16, 2023, 11:00 am